Baxter (BAX) board chair David Brent Shafer receives 12,836-share stock grant

Rhea-AI Filing Summary

Shafer David Brent reported acquisition or exercise transactions in this Form 4 filing.

Baxter International Inc. director and Chair of the Board David Brent Shafer received an equity grant of 12,836 fully vested shares of Baxter common stock. The shares were granted at no cash cost to him and are subject to the applicable grant terms and conditions.

Following this award, Shafer directly holds 72,804 Baxter common shares, a figure that includes shares added through the automatic reinvestment of dividends. This filing reflects a compensation-related stock grant rather than an open‑market purchase or sale.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Shafer David Brent

Role null

Type	Security	Shares	Price	Value
Grant/Award	Common Stock, $1 par value	12,836	$0.00	--

Holdings After Transaction: Common Stock, $1 par value — 72,804 shares (Direct, null)

Footnotes (1)

1. The reporting person received a grant of fully vested shares of common stock of Baxter International Inc., subject to the terms and conditions of the applicable grant. Total includes the automatic reinvestment of dividends.

Key Figures

Stock grant size: 12,836 shares Post-grant holdings: 72,804 shares Grant price per share: $0.0000 per share

3 metrics

Stock grant size 12,836 shares Fully vested Baxter common stock grant to David Brent Shafer

Post-grant holdings 72,804 shares Direct Baxter common stock owned by Shafer after grant, includes dividend reinvestment

Grant price per share $0.0000 per share Reported price on Form 4 for awarded Baxter common shares

Key Terms

fully vested shares, automatic reinvestment of dividends, Grant, award, or other acquisition, Common Stock, $1 par value

4 terms

fully vested shares financial

"The reporting person received a grant of fully vested shares of common stock of Baxter International Inc."

automatic reinvestment of dividends financial

"Total includes the automatic reinvestment of dividends."

Grant, award, or other acquisition financial

"transaction_code_description": "Grant, award, or other acquisition"

Common Stock, $1 par value financial

"security_title": "Common Stock, $1 par value"

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Shafer David Brent

(Last) (First) (Middle)

ONE BAXTER PARKWAY

(Street)

DEERFIELD ILLINOIS 60015

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
BAXTER INTERNATIONAL INC [ BAX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)	X	Other (specify below)
			Chair of the Board

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/05/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, $1 par value	05/05/2026		A		12,836(1)	A	$0	72,804(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The reporting person received a grant of fully vested shares of common stock of Baxter International Inc., subject to the terms and conditions of the applicable grant.

2. Total includes the automatic reinvestment of dividends.

Remarks:

	/s/ Kimberly Olson, as attorney in-fact for David Brent Shafer	05/07/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did Baxter (BAX) director David Brent Shafer report in this Form 4?

David Brent Shafer reported receiving an equity grant of 12,836 fully vested Baxter common shares. The shares were awarded as compensation under Baxter’s grant terms, not bought on the open market, and increase his direct ownership stake in the company’s common stock.

How many Baxter (BAX) shares were granted to David Brent Shafer?

He was granted 12,836 shares of Baxter common stock. According to the disclosure, these shares are fully vested upon grant and are issued at no stated purchase price per share, reflecting a stock-based compensation award rather than a cash-funded acquisition.

What are David Brent Shafer’s Baxter (BAX) holdings after this transaction?

After the grant, Shafer directly owns 72,804 Baxter common shares. This total explicitly includes shares accumulated through the automatic reinvestment of dividends, giving a consolidated view of his direct common stock position following the reported award.

Was the Baxter (BAX) share grant to David Brent Shafer an open-market trade?

No, the transaction reflects a grant of fully vested common shares as compensation. The Form 4 shows a transaction code "A" for a grant or award, with a reported price of $0.0000 per share, confirming it was not an open-market purchase or sale.

Did the Baxter (BAX) Form 4 include any derivative securities for David Brent Shafer?

The filing does not show any derivative security transactions for Shafer in this report. Only a non-derivative grant of 12,836 fully vested Baxter common shares is disclosed, and the derivative holdings summary is empty in the provided data.